Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Beecham divestitures

Executive Summary

British firm announces plans to sell seven of its non-health care units in order to focus on its Rx and OTC pharmaceutical businesses. Among the units reportedly earmarked for divestiture are the Germaine Monteil cosmetics business; the firm's home improvement division, which includes the DAP subsidiary acquired from Schering in 1983; and its wine and spirits business. In a June 12 letter to the trade, Germaine Monteil explained that "following a series of disappointing quarterly results, [Beecham] embarked on a program of restructuring its top management and concentrating its business base in proprietary and over-the-counter products." Beecham acquired Revlon's Norcliff Thayer OTC business and Reheis chemical business last fall for approximately $400 mil.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS010283

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel